v3.26.1
REVENUES (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates the Company’s revenues by major revenue streams.

 

Revenue stream:          
   Years Ended December 31, 
   2024   2023 
   (in thousands) 
Revenue stream:          
Cell process development services and hospital services  $1,020   $515 
License fees   15    15 
Total  $1,035   $530 

SCHEDULE OF BREAKDOWN OF REVENUES PER CUSTOMER

A breakdown of the revenues per customer what constituted at least 10% of revenues is as follows:

 

   2024   2023 
   Years Ended December 31, 
   2024   2023 
   (in thousands) 
Revenue earned:          
Customer A (United States)   492    - 
Customer B (United States)   300    280 
Customer C (United States)   -    90 
Customer D (United States)   150    280 
SCHEDULE OF ACTIVITY FOR TRADE RECEIVABLES

The activity for accounts receivable is comprised of:

 

   2024   2023 
   Years Ended December 31, 
   2024   2023 
   (in thousands) 
         
Balance as of beginning of period  $88   $36,183 
Deconsolidation of Octomera   82    (5,985)
Additions   670    560 
Collections   (1,268)   (6,230)
Allowances for credit losses   469    (24,388)
Exchange rate differences   (1)   (52)
Balance as of end of period  $40   $88 
SCHEDULE OF ACTIVITY FOR CONTRACT LIABILITIES

The activity for contract liabilities is comprised of:

 

   2024   2023 
   Years Ended December 31, 
   2024   2023 
   (in thousands) 
         
Balance as of beginning of period  $200   $70 
Reconsolidation (deconsolidation) of Octomera   110    (106)
Deconsolidation of OBI   (60)   - 
Additions   300    236 
Realizations   (445)   - 
Balance as of end of period  $105   $200